DOCSLIB.ORG

Asymptomatic Microscopic Hematuria in Adults: Summary of the AUA Best Practice Policy Recommendations GARY D

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Asymptomatic Microscopic Hematuria in Adults: Summary of the AUA Best Practice Policy Recommendations GARY D Asymptomatic Microscopic Hematuria in Adults: Summary of the AUA Best Practice Policy Recommendations GARY D. GROSSFELD, M.D., University of California, San Francisco, School of Medicine, San Francisco, California J. STUART WOLF, JR., M.D., University of Michigan Medical School, Ann Arbor, Michigan MARK S. LITWIN, M.D., M.P.H., University of California, Los Angeles, Schools of Medicine and Public Health, Los Angeles, California HEDVIG HRICAK, M.D., PH.D., Memorial Sloan-Kettering Cancer Center, New York, New York CATHRYN L. SHULER, M.D., Kaiser Permanente, Portland, Oregon DAVID C. AGERTER, M.D., Mayo Clinic, Rochester, Minnesota PETER R. CARROLL, M.D., University of California, San Francisco, School of Medicine, San Francisco, California The American Urological Association (AUA) convened the Best Practice Policy Panel on Asympto- matic Microscopic Hematuria to formulate policy statements and recommendations for the evalu- ation of asymptomatic microhematuria in adults. The recommended definition of microscopic hematuria is three or more red blood cells per high-power microscopic field in urinary sediment from two of three properly collected urinalysis specimens. This definition accounts for some degree of hematuria in normal patients, as well as the intermittent nature of hematuria in patients with urologic malignancies. Asymptomatic microscopic hematuria has causes ranging from minor findings that do not require treatment to highly significant, life-threatening lesions. Therefore, the AUA recommends that an appropriate renal or urologic evaluation be performed in all patients with asymptomatic microscopic hematuria who are at risk for urologic disease or primary renal dis- ease. At this time, there is no consensus on when to test for microscopic hematuria in the primary care setting, and screening is not addressed in this report. However, the AUA report suggests that the patient’s history and physical examination should help the physician decide whether testing is appropriate. (Am Fam Physician 2001;63:1145-54.) lood in the urine (hematuria) members’ expert opinions. In addition to urol- can originate from any site along ogists, the multispecialty panel included a fam- the urinary tract and, whether ily physician, a nephrologist and a radiologist. gross or microscopic, may be a Funding in support of panel activities was pro- sign of serious underlying dis- vided by the AUA. A summary of the recom- Bease, including malignancy. The literature mendations is presented in this article; the full agrees that gross hematuria warrants a thor- text will be published in Urology.3,4 ough diagnostic evaluation.1 By contrast, microscopic hematuria is an incidental find- The initial determination of microscopic hema- ing, and whether physicians should test for turia should be based on microscopic examina- hematuria in asymptomatic patients remains tion of urinary sediment from a freshly voided, at issue. No major organization currently rec- clean-catch, midstream urine specimen. ommends screening for microscopic hema- Hematuria can be measured quantitatively turia in asymptomatic adults, even though by any of the following: (1) determination of bladder cancer is the most commonly de- the number of red blood cells per milliliter of tected malignancy in such patients.2 urine excreted (chamber count), (2) direct The American Urological Association (AUA) examination of the centrifuged urinary sedi- convened a Best Practice Policy Panel to for- ment (sediment count) or (3) indirect exami- mulate recommendations for the evaluation of nation of the urine by dipstick (the simplest patients with asymptomatic microhematuria. way to detect microscopic hematuria). Given The panel does not offer recommendations the limited specificity of the dipstick method regarding routine screening for microscopic (65 percent to 99 percent for two to five red hematuria. The recommendations are based on blood cells per high-power microscopic field), extensive review of the literature and the panel however, the initial finding of microscopic MARCH 15, 2001 / VOLUME 63, NUMBER 6 www.aafp.org/afp AMERICAN FAMILY PHYSICIAN 1145 The recommended definition of microscopic hematuria is TABLE 1 Risk Factors for Significant Disease three or more red blood cells per high-power field on in Patients with Microscopic Hematuria microscopic evaluation of urinary sediment from two of three properly collected urinalysis specimens. Smoking history Occupational exposure to chemicals or dyes (benzenes or aromatic amines) hematuria by the dipstick method should be History of gross hematuria confirmed by microscopic evaluation of uri- Age >40 years History of urologic disorder or disease nary sediment.5-8 History of irritative voiding symptoms The recommended definition of micro- History of urinary tract infection scopic hematuria is three or more red blood Analgesic abuse cells per high-power field on microscopic History of pelvic irradiation evaluation of urinary sediment from two of three properly collected urinalysis specimens. Adapted with permission from Grossfeld GD, Wolf To account for intermittent positive tests for JS, Litwin MS, Hricak H, Shuler CL, Agerter DC, Car- hematuria in patients with urologic malig- roll P. Evaluation of asymptomatic microscopic nancies,6,9 one group of investigators10 pro- hematuria in adults: the American Urological Associ- ation best practice policy recommendations. Part II: posed that patients with more than three red patient evaluation, cytology, voided markers, imag- blood cells per high-power field from two of ing, cystoscopy, nephrology evaluation, and follow- three properly collected urine specimens up. Urology 2001;57(4) (In press). should be considered to have microhematuria and, thus, should be evaluated appropriately. However, before a decision is made to defer evaluation in patients with one or two red Patients with asymptomatic microscopic blood cells per high-power field, risk factors hematuria who are at risk for urologic disease for significant disease should be taken into or primary renal disease should undergo an consideration (Table 1).4 High-risk patients appropriate evaluation. In patients at low risk should be considered for full urologic evalua- for disease, some components of the evaluation tion after one properly performed urinalysis may be deferred. documenting the presence of at least three red Asymptomatic microscopic hematuria has blood cells per high-power field. many causes, ranging from minor incidental findings that do not require treatment to The prevalence of asymptomatic microscopic highly significant lesions that are immediately hematuria varies from 0.19 percent to as high life-threatening. Therefore, hematuria has as 21 percent. been classified into four categories: life- In five population-based studies, the preva- threatening; significant, requiring treatment; lence of asymptomatic microscopic hematuria significant, requiring observation; and varied from 0.19 percent to 16.1 percent.7 Dif- insignificant1,10 (Table 2).1 ferences in the age and sex of the populations Most studies in which patients with asymp- screened, the amount of follow-up and the tomatic microscopic hematuria have under- number of screening studies per patient gone full urologic evaluation (often including account for this range. In older men, who are repeat urinalysis, urine culture, upper urinary at a higher risk for significant urologic disease, tract imaging, cystoscopy and urinary cytol- the prevalence of asymptomatic microscopic ogy) have included referral-based popula- hematuria was as high as 21 percent.6,9,11-13 tions. A cause for asymptomatic microscopic 1146 AMERICAN FAMILY PHYSICIAN www.aafp.org/afp VOLUME 63, NUMBER 6 / MARCH 15, 2001 Hematuria TABLE 2 Reported Causes of Asymptomatic Microscopic Hematuria The rightsholder did not grant rights to reproduce this item in electronic media. For the missing item, see the original print version of this publication. hematuria was determined in 32 percent to tors suggest the presence of renal parenchymal 100 percent of these patients.6,9-23 disease. In the absence of massive bleeding, a An algorithm for the initial evaluation of total protein excretion in excess of 1,000 mg newly diagnosed asymptomatic microscopic per 24 hours would be unlikely and should hematuria is provided in Figure 1.4 An prompt a thorough evaluation or nephrology approach to the urologic evaluation of referral24 (Figure 2).4 patients without conditions suggestive of pri- Red cell casts are virtually pathognomonic mary renal disease is presented in Figure 2.4 for glomerular bleeding. Unfortunately, they are a relatively insensitive marker. Therefore, The presence of significant proteinuria, red cell it is useful to examine the character of the red casts or renal insufficiency, or a predominance of blood cells.25 Dysmorphic urinary red blood dysmorphic red blood cells in the urine should cells show variation in size and shape and prompt an evaluation for renal parenchymal usually have an irregular or distorted outline. disease or referral to a nephrologist. Such red blood cells are generally glomerular Significant proteinuria is defined as a total in origin. In contrast, normal doughnut- protein excretion of greater than 1,000 mg per shaped red blood cells are generally due to 24 hours (1 g per day), or greater than 500 mg lower urinary tract bleeding. Accurate deter- per 24 hours (0.5 g per day) if protein excre- mination of red blood cell morphology may tion is persistent or increasing or if other fac- require
Load more

Recommended publications
  • Chapter 99 – Urological Disorders Episode Overview Urinary Tract Infections in Adults 1
    Crack Cast Show Notes – Urological Disorders – August 2017 www.crackcast.org Chapter 99 – Urological Disorders Episode Overview Urinary Tract Infections in Adults 1. Differentiate between the three major causes of dysuria in women? (ddx of dysuria) 2. List 3 common UTI pathogens, and list 3 additional pathogens in complicated UTIs 3. Define uncomplicated UTI and antibiotic options 4. Define complicated UTI and antibiotic options 5. List two antibiotic options for uncomplicated and complicated pyelonephritis. 6. How is pyelonephritis managed in pregnancy? What are safe antibiotic options for bacteriuria in pregnancy? Prostatitis 1. Describe the diagnosis and management of prostatitis Renal Calculi 1. Name the areas of narrowing in the ureter 2. Name 6 risk factors for urolithiasis 3. List 8 alternative diagnoses (other than renal colic) for pain associated with urolithiasis 4. What are indications for hospitalization of patients with urolithiasis Bladder (Vesical) Calculi 1. Describe this condition and its management Acute Scrotal Pain 1. List causes of acute scrotal swelling by age groups (infant, child, adolescent, adult) 2. Describe the physiology, diagnosis and management of testicular torsion 3. Describe the treatment for sexually vs. non-sexually acquired epididymitis Acute Urinary Retention 1. Describe the physiology of urination 2. List 10 causes of acute urinary retention in adults 3. List 6 causes of urinary retention in women Hematuria 1. List causes of red-coloured urine without hematuria 2. List risk factors for urinary tract malignancy Wisecracks: 1. When is a urine culture indicated (box 89.1) 2. What is a CAUTI and how is it managed? 3. What are two medication classes of drugs for prostatic enlargement? 4.
    [Show full text]
  • Prevalence of Microhematuria in Renal Colic and Urolithiasis: a Systematic Review and Meta-Analysis
    Minotti et al. BMC Urology (2020) 20:119 https://doi.org/10.1186/s12894-020-00690-7 RESEARCH ARTICLE Open Access Prevalence of microhematuria in renal colic and urolithiasis: a systematic review and meta-analysis Bruno Minotti1* , Giorgio Treglia2, Mariarosa Pascale3, Samuele Ceruti4, Laura Cantini5, Luciano Anselmi5 and Andrea Saporito5 Abstract Background: This systematic review and meta-analysis aims to investigate the prevalence of microhematuria in patients presenting with suspected acute renal colic and/or confirmed urolithiasis at the emergency department. Methods: A comprehensive literature search was conducted to find relevant data on prevalence of microhematuria in patients with suspected acute renal colic and/or confirmed urolithiasis. Data from each study regarding study design, patient characteristics and prevalence of microhematuria were retrieved. A random effect-model was used for the pooled analyses. Results: Forty-nine articles including 15′860 patients were selected through the literature search. The pooled microhematuria prevalence was 77% (95%CI: 73–80%) and 84% (95%CI: 80–87%) for suspected acute renal colic and confirmed urolithiasis, respectively. This proportion was much higher when the dipstick was used as diagnostic test (80 and 90% for acute renal colic and urolithiasis, respectively) compared to the microscopic urinalysis (74 and 78% for acute renal colic and urolithiasis, respectively). Conclusions: This meta-analysis revealed a high prevalence of microhematuria in patients with acute renal colic (77%), including those with confirmed urolithiasis (84%). Intending this prevalence as sensitivity, we reached moderate values, which make microhematuria alone a poor diagnostic test for acute renal colic or urolithiasis. Microhematuria could possibly still important to assess the risk in patients with renal colic.
    [Show full text]
  • Doenças Infeciosas Do Rim – Revisão Pictórica
    ACTA RADIOLÓGICA PORTUGUESA Maio-Agosto 2014 nº 102 Volume XXVI 37-43 Artigo de Revisão / Review Article DOENÇAS INFECIOSAS DO RIM – REVISÃO PICTÓRICA INFECTIOUS DISEASES OF THE KIDNEY – A PICTORIAL REVIEW Ângela Figueiredo1, Luísa Andrade2, Hugo Correia1, Nuno Ribeiro1, Rui Branco1, Duarte Silva1 1 - Serviço de Radiologia do Centro Hospitalar Resumo Abstract Tondela - Viseu Diretor: Dr. Duarte Silva A pielonefrite aguda é o tipo de infeção renal Acute pyelonephritis is the most common 2 - Serviço de Imagem Médica do Centro mais frequente, no entanto, o rim pode ser renal infection but a variety of other Hospitalar e Universitário de Coimbra afetado por vários outros processos infectious processes can be seen in the kidney. Diretor: Prof. Doutor Filipe Caseiro Alves infeciosos. Embora a avaliação imagiológica Although radiologic evaluation is not não seja necessária nos casos de pielonefrite necessary in cases of uncomplicated não complicada, pode desempenhar um papel pyelonephritis, it plays an important role in Correspondência importante nos doentes de risco, nos que não high-risk patients and in those who do not respondem de modo adequado à terapêutica respond to therapy or whose clinical Ângela Figueiredo e naqueles com uma apresentação clínica presentation is atypical. Serviço de Radiologia atípica. Although ultrasonography (US) is relatively Centro Hospitalar Tondela-Viseu A ecografia, embora pouco sensível nas fases insensitive in early stages of acute Av. Rei D. Duarte iniciais da pielonefrite, é o exame de primeira pyelonephritis, it is considered the first level 3504-509 Viseu linha por ser uma técnica acessível e não investigation technique for its availability and e-mail: [email protected] utilizar radiação ionizante.
    [Show full text]
  • Urinary System Diseases and Disorders
    URINARY SYSTEM DISEASES AND DISORDERS BERRYHILL & CASHION HS1 2017-2018 - CYSTITIS INFLAMMATION OF THE BLADDER CAUSE=PATHOGENS ENTERING THE URINARY MEATUS CYSTITIS • MORE COMMON IN FEMALES DUE TO SHORT URETHRA • SYMPTOMS=FREQUENT URINATION, HEMATURIA, LOWER BACK PAIN, BLADDER SPASM, FEVER • TREATMENT=ANTIBIOTICS, INCREASE FLUID INTAKE GLOMERULONEPHRITIS • AKA NEPHRITIS • INFLAMMATION OF THE GLOMERULUS • CAN BE ACUTE OR CHRONIC ACUTE GLOMERULONEPHRITIS • USUALLY FOLLOWS A STREPTOCOCCAL INFECTION LIKE STREP THROAT, SCARLET FEVER, RHEUMATIC FEVER • SYMPTOMS=CHILLS, FEVER, FATIGUE, EDEMA, OLIGURIA, HEMATURIA, ALBUMINURIA ACUTE GLOMERULONEPHRITIS • TREATMENT=REST, SALT RESTRICTION, MAINTAIN FLUID & ELECTROLYTE BALANCE, ANTIPYRETICS, DIURETICS, ANTIBIOTICS • WITH TREATMENT, KIDNEY FUNCTION IS USUALLY RESTORED, & PROGNOSIS IS GOOD CHRONIC GLOMERULONEPHRITIS • REPEATED CASES OF ACUTE NEPHRITIS CAN CAUSE CHRONIC NEPHRITIS • PROGRESSIVE, CAUSES SCARRING & SCLEROSING OF GLOMERULI • EARLY SYMPTOMS=HEMATURIA, ALBUMINURIA, HTN • WITH DISEASE PROGRESSION MORE GLOMERULI ARE DESTROYED CHRONIC GLOMERULONEPHRITIS • LATER SYMPTOMS=EDEMA, FATIGUE, ANEMIA, HTN, ANOREXIA, WEIGHT LOSS, CHF, PYURIA, RENAL FAILURE, DEATH • TREATMENT=LOW NA DIET, ANTIHYPERTENSIVE MEDS, MAINTAIN FLUIDS & ELECTROLYTES, HEMODIALYSIS, KIDNEY TRANSPLANT WHEN BOTH KIDNEYS ARE SEVERELY DAMAGED PYELONEPHRITIS • INFLAMMATION OF THE KIDNEY & RENAL PELVIS • CAUSE=PYOGENIC (PUS-FORMING) BACTERIA • SYMPTOMS=CHILLS, FEVER, BACK PAIN, FATIGUE, DYSURIA, HEMATURIA, PYURIA • TREATMENT=ANTIBIOTICS,
    [Show full text]
  • Role of Urinalysis in the Diagnosis of Chronic Kidney Disease (CKD)
    Research and Reviews Role of Urinalysis in the Diagnosis of Chronic Kidney Disease (CKD) JMAJ 54(1): 27–30, 2011 Kunitoshi ISEKI*1 Abstract As of the end of Year 2008, 1 out of 450 people was a dialysis patient in Japan, and patients with chronic kidney disease (CKD) at stages 3 and 4 accounted for nearly 10% of the total population. An epidemiological study in Okinawa that used the introduction of dialysis treatment as the outcome revealed that the 10-year cumulative incident rate of end-stage renal disease (ESRD) was about 3% of the participants who were positive (Ն 1ϩ) for both proteinuria and hematuria, while there was hardly any difference between those who were positive for hematuria alone and those who were negative for both proteinuria and hematuria. When the incidence of ESRD (dialysis introduction) was examined in relation to the severity of proteinuria (5 grades ranging from [Ϫ] to [Ն 3ϩ]) as determined by dipstick, the cumulative incidence rate during the 17-year observation period was 16% for proteinuria (Ն 3ϩ) and about 7% for proteinuria (2ϩ). In contrast, among participants who were negative for proteinuria, the rate of dialysis introduction in 10 years is about 1 out of 1 million. The CKD Practice Guide of the Japanese Society of Nephrology recommends referral to a nephrologist when a case meets any of the following 3 criteria: 1) 0.5g/g creatinine or higher, or proteinuria (Ն 2ϩ), 2) an estimated glomerular filtration rate of less than 50ml/min/1.73m2, or 3) positive results (Ն 1ϩ) for both proteinuria and hematuria tests.
    [Show full text]
  • Hematuria in the Child
    Hematuria and Proteinuria in the Pediatric Patient Laurie Fouser, MD Pediatric Nephrology Swedish Pediatric Specialty Care Hematuria in the Child • Definition • ³ 1+ on dipstick on three urines over three weeks • 5 RBCs/hpf on three fresh urines over three weeks • Prevalence • 4-6% for microscopic hematuria on a single specimen in school age children • 0.3-0.5% on repeated specimens Sources of Hematuria • Glomerular or “Upper Tract” – Dysmorphic RBCs and RBC casts – Tea or cola colored urine – Proteinuria, WBC casts, renal tubular cells • Non-Glomerular or “Lower Tract” – RBCs have normal morphology – Clots/ Bright red or pink urine The Glomerular Capillary Wall The Glomerular Capillary Wall Glomerular Causes of Hematuria • Benign or self-limiting – Benign Familial Hematuria – Exercise-Induced Hematuria – Fever-Induced Hematuria Glomerular Causes of Hematuria • Acute Glomerular Disease – Poststreptococcal/ Postinfectious – Henoch-Schönlein Purpura – Sickle Cell Disease – Hemolytic Uremic Syndrome Glomerular Causes of Hematuria • Chronic Glomerular Disease – IgA Nephropathy – Henoch-Schönlein Purpura or other Vasculitis – Alport Syndrome – SLE or other Collagen Vascular Disease – Proliferative Glomerulonephritis Non-Glomerular Hematuria • Extra-Renal • UTI • Benign urethralgia +/- meatal stenosis • Calculus • Vesicoureteral Reflux, Hydronephrosis • Foreign body • Rhabdomyosarcoma • AV M • Coagulation disorder Non-Glomerular Hematuria • Intra-Renal • Hypercalciuria • Polycystic Kidney Disease • Reflux Nephropathy with Renal Dysplasia •
    [Show full text]
  • Development and Validation of a Model to Predict Severe Hospital-Acquired Acute Kidney Injury in Non-Critically Ill Patients
    Journal of Clinical Medicine Article Development and Validation of a Model to Predict Severe Hospital-Acquired Acute Kidney Injury in Non-Critically Ill Patients Jacqueline Del Carpio 1,2,3,*, Maria Paz Marco 1,3, Maria Luisa Martin 1,3, Natalia Ramos 4 , Judith de la Torre 4,5, Joana Prat 6,7, Maria J. Torres 6,8, Bruno Montoro 9, Mercedes Ibarz 3,10 , Silvia Pico 3,10, Gloria Falcon 11, Marina Canales 11, Elisard Huertas 12, Iñaki Romero 13, Nacho Nieto 6,8, Ricard Gavaldà 14 and Alfons Segarra 1,4,† 1 Department of Nephrology, Arnau de Vilanova University Hospital, 25198 Lleida, Spain; [email protected] (M.P.M.); [email protected] (M.L.M.); [email protected] (A.S.) 2 Department of Medicine, Autonomous University of Barcelona, 08193 Barcelona, Spain 3 Institute of Biomedical Research (IRBLleida), 25198 Lleida, Spain; [email protected] (M.I.); [email protected] (S.P.) 4 Department of Nephrology, Vall d’Hebron University Hospital, 08035 Barcelona, Spain; [email protected] (N.R.); [email protected] (J.d.l.T.) 5 Department of Nephrology, Althaia Foundation, 08243 Manresa, Spain 6 Department of Informatics, Vall d’Hebron University Hospital, 08035 Barcelona, Spain; [email protected] (J.P.); [email protected] (M.J.T.); [email protected] (N.N.) 7 Department of Development, Parc Salut Hospital, 08019 Barcelona, Spain 8 Department of Information, Southern Metropolitan Territorial Management, 08028 Barcelona, Spain 9 Department of Hospital Pharmacy, Vall d’Hebron University Hospital, 08035 Barcelona, Spain; [email protected] Citation: Carpio, J.D.; Marco, M.P.; 10 Laboratory Department, Arnau de Vilanova University Hospital, 25198 Lleida, Spain Martin, M.L.; Ramos, N.; de la Torre, 11 Technical Secretary and Territorial Management of Lleida-Pirineus, 25198 Lleida, Spain; J.; Prat, J.; Torres, M.J.; Montoro, B.; [email protected] (G.F.); [email protected] (M.C.) 12 Ibarz, M.; Pico, S.; et al.
    [Show full text]
  • Hematuria Is a Risk Factor Towards End-Stage Renal
    Nephrology and Renal Diseases Research Article Hematuria is a risk factor towards end-stage renal disease - A propensity score analysis Tomoko Shima* Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan Abstract Background: It remains unclear whether microscopic hematuria accelerates the progression of chronic kidney disease (CKD). Since the risk of microscopic hematuria was expected very weak, we employed a propensity score analysis. Methods: A retrospective CKD cohort of 803 participants in a single institution was analyzed. The degree of microscopic hematuria was scaled as 0, 0.5, 1, 2, 3 for negative, ±, 1+, 2+, 3+ in the urinary qualitative analysis by dipstick, respectively. Time-averaged microscopic hematuria (TA-MH) was calculated by trapezoidal rule. The propensity score was estimated using 23 baseline covariates by multivariate binary logistic regression for the threshold of TA-MH at ≥ 0.5 or ≥ 1.0. Kaplan-Meier analysis after propensity score matching was also examined. Results: The incidence rate of end-stage renal disease (ESRD) was 33.9 per 1,000 person-years over median follow-up of 4.3 years. A Cox regression analysis stratified by quintile on the propensity scores showed that TA-MH ≥ 0.5 was a risk for ESRD (HR 1.72, 95% CI 1.08-2.75, p = 0.023) but not TA-MH ≥ 1.0 (HR 1.34, 95% CI 0.76-2.40, p = 0.315). Kaplan-Meier analysis after propensity score matching reproduced the similar results (TA-MH ≥ 0.5, HR 1.80, 95% CI 1.03-3.12, p = 0.046; TA-MH ≥ 1.0, HR 1.73, 95% CI 0.84-3.54, p = 0.145).
    [Show full text]
  • Blood Or Protein in the Urine: How Much of a Work up Is Needed?
    Blood or Protein in the Urine: How much of a work up is needed? Diego H. Aviles, M.D. Disclosure • In the past 12 months, I have not had a significant financial interest or other relationship with the manufacturers of the products or providers of the services discussed in my presentation • This presentation will not include discussion of pharmaceuticals or devices that have not been approved by the FDA Screening Urinalysis • Since 2007, the AAP no longer recommends to perform screening urine dipstick • Testing based on risk factors might be a more effective strategy • Many practices continue to order screening urine dipsticks Outline • Hematuria – Definition – Causes – Evaluation • Proteinuria – Definition – Causes – Evaluation • Cases You are about to leave when… • 10 year old female seen for 3 day history URI symptoms and fever. Urine dipstick showed 2+ for blood and no protein. Questions? • What is the etiology for the hematuria? • What kind of evaluation should be pursued? • Is this an indication of a serious renal condition? • When to refer to a Pediatric Nephrologist? Hematuria: Definition • Dipstick > 1+ (large variability) – RBC vs. free Hgb – RBC lysis common • > 5 RBC/hpf in centrifuged urine • Can be – Microscopic – Macroscopic Hematuria: Epidemiology • Microscopic hematuria occurs 4-6% with single urine evaluation • 0.1-0.5% of school children with repeated testing • Gross hematuria occurs in 1/1300 Localization of Hematuria • Kidney – Brown or coke-colored urine – Cellular casts • Lower tract – Terminal gross hematuria – (Blood
    [Show full text]
  • Diagnostic Utility of Microhematuria in Renal Colic Patients in Emergency Medicine: Correlation with Findings from Multidetector Computed Tomography
    Available online at www.medicinescience.org Medicine Science ORIGINAL RESEARCH International Medical Journal Medicine Science 2019; ( ): Diagnostic utility of microhematuria in renal colic patients in emergency medicine: correlation with findings from multidetector computed tomography Murat Daş ORCID: 0000-0003-0893-6084 Okan Bardakci ORCID: 0000-0001-6829-7435 Erşan Yurtseven ORCID: 0000-0003-0469-5260 Canan Akman ORCID: 0000-0002-3427-5649 Yavuz Beyazit ORCID: 0000-0001-6247-2714 Okhan Akdur ORCID: 0000-0003-3099-6876 1Canakkale Onsekiz Mart Universty, Faculty of Medicine, Department of Emergency Medicine, Canakkale, Turkey 2Canakkale Onsekiz Mart Universty, Department of Internal Medicine, Canakkale, Turkey Received 19 November2018; Accepted 28 December 2018 Available online 30.01.2019 with doi:10.5455/medscience.2018.07.8974 Copyright © 2019 by authors and Medicine Science Publishing Inc. Abstract Although urine analysis is a simple and inexpensive method for the initial evaluation of renal colic patients presenting in emergency departments, it is regarded as unreliable for an exact diagnosis of urinary system stones. The aim of the present study is to assess the association between clinical demographics, and stone size and location, with the combined utility of urinalysis and unenhanced multidetector computed tomography (MDCT) in the emergency department. After gaining local Ethics Committee approval, a retrospective study was conducted with data from 186 patients who presented at our emergency service with flank pain and documented urolithiasis. Stone location and size was determined by MDCT, and the presence of microhematuria confirmed by urinalysis. The presence of hydronephrosis and clinical complaints were also recorded. A total of 186 patients were included in the present study, in which an absence of microhematuria was recorded in 24.7% patients.
    [Show full text]
  • Microhematuria and Urinary Tract Infections
    1/30/2018 MICROHEMATURIA AND URINARY TRACT INFECTIONS ANEESA HUSAIN, PA-C USMD CANCER CENTER ARLINGTON - UROLOGY I HAVE NO FINANCIAL DISCLOSURES THAT WOULD BE A POTENTIAL CONFLICT OF INTEREST WITH THIS PRESENTATION. MICROHEMATURIA TOPICS OF DISCUSSION • DEFINITION • HISTORY • PHYSICAL EXAM • DIFFERENTIAL DIAGNOSES • WORK UP • TREATMENT • WHEN TO REFER? 1 1/30/2018 MICROHEMATURIA DEFINED AS.. • ≥3 RBCs per HPF (HIGH POWER FIELD) ON URINE MICROSCOPY • SHOULD NOT BASE SOLELY ON ONE DIPSTICK READING • CAN CORRELATE TO DIPSTICK URINE ANALYSIS • TRACE, SMALL, MODERATE, LARGE https://www.auanet.org/guidelines/asymptomatic-microhematuria-(2012-reviewed-and-validity-confirmed-2016) MICROHEMATURIA TOP DIFFERENTIAL DIAGNOSES • UTI/PROSTATITIS • KIDNEY STONES • URINARY TRACT OBSTRUCTION • URINARY TRACT MALIGNANCY • NEPHROLOGIC SOURCES MICROHEMATURIA HISTORY • NEW DIAGNOSIS OF MICROHEMATURIA? • PRIOR HISTORY OF GROSS OR MICROHEMATURIA? • PRIOR WORK UP • COMORBIDITIES • PELVIC RADIATION • SURGICAL HISTORY • FOR WOMEN, ASK ABOUT MENSES AND/OR MENOPAUSE • ANTICOAGULATION OR BLOOD THINNERS • SYMPTOMS 2 1/30/2018 MICROHEMATURIA HISTORY - SYMPTOMS • DYSURIA • FREQUENCY • URGENCY • DIFFICULTY VOIDING • INCONTINENCE – PAD USAGE • ABDOMINAL OR BACK PAIN • PERINEAL PAIN MICROHEMATURIA PHYSICAL EXAM • ABDOMINAL EXAM • CVA/FLANK TENDERNESS • GU EXAM • MALE – CONSIDER MEATAL STENOSIS, BALANITIS, TESTICULAR PAIN, PROSTATITIS, PROSTATE ENLARGEMENT • FEMALE – CONSIDER VAGINAL BLEEDING, YEAST INFECTION, ATROPHIC VAGINITIS MICROHEMATURIA DIFFERENTIAL DIAGNOSES • UTI/PROSTATITIS
    [Show full text]
  • 2. Evaluation of Asymptomatic Hematuria and Proteinuria in Adult Primary Care
    PRACTICE Nephrology: 2. Evaluation of asymptomatic hematuria and proteinuria in adult primary care Andrew A. House, Daniel C. Cattran Case 1 Ms. M, a 27-year-old woman with a complaint of mild fatigue, is found to have a positive uri- nary dipstick test for hematuria. The patient does not have gross hematuria, voiding symp- toms, renal colic or symptoms of systemic disease, such as infection or connective tissue dis- ease. She is not currently experiencing menstrual bleeding. She has never been known to have hematuria, although she has experienced occasional lower urinary tract infections. There is no history of occupational exposure to carcinogens, and Ms. M has been a lifelong nonsmoker. The family history is unremarkable with respect to renal disease. Physical examination reveals a blood pressure of 110/70 mm Hg, no edema, rash or abdominal findings. Does Ms. M have hematuria? Is the source glomerular or nonglomerular? Is she likely to have a serious urinary tract pathology such as a malignancy? What investigations are needed to determine the need for referral and the urgency of referral? Case 2 Mr. A, a 30-year-old man, is turned down for life insurance because of the presence of an un- specified amount of proteinuria. His past medical history is unremarkable, and he is not taking any medications. There is no history of diabetes or hypertension. His family history is negative for diabetes or renal diseases. At the time of assessment, Mr. A is a cigarette smoker but says that he does not consume alcohol or use recreational drugs. He has no voiding symptoms or anything suggestive of a systemic infectious or inflammatory condition.
    [Show full text]